These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11326681)

  • 1. Immunohistochemical investigation with carbohydrate monoclonal antibodies in cystic fibrosis.
    Makovitzky J; Götze S
    Anticancer Res; 2000; 20(6D):5121-3. PubMed ID: 11326681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical analysis of CA19-9, SLX, and CA125 in adenoid cystic carcinoma of trachea and bronchus].
    Tamura S; Yamaguchi K; Terada M; Nakano T; Maeda J; Iwahashi N; Hada T; Higashino K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Mar; 30(3):407-11. PubMed ID: 1314919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW; Jiang B; Han CZ; Jing JX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical studies of mucinous mammary carcinomas and their metastases.
    Gunkel L; Mylonas I; Richter DU; Makovitzky J
    Anticancer Res; 2005; 25(3A):1755-9. PubMed ID: 16033095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the carbohydrate tumour marker SLeX, SLeA (CA19-9), LeY and Thomsen-Friedenreich (TF) antigen on normal squamous epithelial tissue of the penis and vagina.
    Wiest I; Schulze S; Kuhn C; Seliger C; Hausmann R; Betz P; Mayr D; Friese K; Jeschke U
    Anticancer Res; 2007; 27(4A):1981-8. PubMed ID: 17649809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C; Bei L; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of carbohydrate antigen 50 and carbohydrate antigen 242 in the diagnosis of colorectal carcinoma].
    Huang CW; Bai L
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1116-8. PubMed ID: 12480590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder.
    Shukla VK; Gurubachan ; Sharma D; Dixit VK; Usha
    Trop Gastroenterol; 2006; 27(4):160-5. PubMed ID: 17542293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CA19-9, CA242].
    Odagiri E
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():685-7. PubMed ID: 20960851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serological test of carbohydrate antigen CA50 in patients with cancer of the digestive tract].
    Takami H; Furuuchi T; Ogata Y; Abe O
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):495-501. PubMed ID: 3468885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M; Visokai V; Lipska L; Topolcan O
    Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.
    Augarten A; Berman H; Aviram M; Diver-Habber A; Akons H; Ben Tur L; Blau H; Kerem E; Rivlin J; Katznelson D; Szeinberg A; Kerem BS; Theodor L; Paret G; Yahav Y
    Clin Exp Med; 2003 Sep; 3(2):119-23. PubMed ID: 14598187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of CA19-9 in mature cystic teratoma].
    Ito K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):524-8. PubMed ID: 1619311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
    Jiang XT; Tao HQ; Zou SC
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer.
    Banfi G; Bravi S; Ardemagni A; Zerbi A
    Int J Biol Markers; 1996; 11(2):77-81. PubMed ID: 8776607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of different carbohydrate tumour markers and galectins 1 and 3 in normal squamous and malignant epithelia of the upper aaerodigestive tract.
    Wiest I; Alexiou C; Kuhn C; Schulze S; Kunze S; Mayr D; Betz P; Jeschke U; Dian D
    Anticancer Res; 2012 May; 32(5):2023-9. PubMed ID: 22593483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
    Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
    Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.